Arcus Biosciences, Inc.

RCUS stock score: 36/100

$19.36 · +1.36% · Scored Oct 22, 2026

Technical
37
Fundamental
35
News
56

The reading

Arcus Biosciences (RCUS) scores 36 out of 100, which reads bearish, higher than 20% of Healthcare stocks and 10% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 37, fundamentals 35.

Among the fundamentals, Price Target at 100 and Revenue Quality (Quarterly) at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 18 and contrarian oscillators 66 — a split worth reading before trusting the technical total.

News sentiment is neutral at 56; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 36 to 68, and it is down 32 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward RCUS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

35

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Revenue Quality (Quarterly)100

    Revenue Quality (Quarterly) evaluates recent revenue performance using trailing 12-month data from quarterly reports.

  • Revenue Growth (Annual)99

    Annual revenue growth tracks year-over-year sales expansion.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Earnings Growth (5-Year)0

    5-year earnings growth evaluates long-term profit trajectory and consistency.

38 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical · daily

24

Pulling it up

  • Bollinger Bands (20)100

    Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Bollinger Bands (50)100

    Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • RSI (14)82

    Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

Holding it back

  • Performance vs SPY0

    Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • SMA 1000

    Simple Moving Average (100-period) provides a longer-term perspective on price trends.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
56

Technical score by timeframe

ChartScoreWeight
Hourly421
Daily243
Weekly362
Monthly472
Quarterly452

Composite score, last 90 days

05010036Jul 25, 2026Oct 22, 2026Jul 25, 2026: 68Jul 26, 2026: 68Jul 27, 2026: 67Jul 28, 2026: 66Jul 29, 2026: 66Jul 30, 2026: 68Jul 31, 2026: 56Aug 2, 2026: 52Aug 3, 2026: 52Aug 5, 2026: 52Aug 6, 2026: 53Aug 7, 2026: 53Aug 8, 2026: 54Aug 9, 2026: 54Aug 10, 2026: 55Aug 11, 2026: 54Aug 12, 2026: 53Aug 13, 2026: 53Aug 14, 2026: 54Aug 15, 2026: 54Aug 16, 2026: 54Aug 17, 2026: 55Aug 18, 2026: 54Aug 19, 2026: 55Aug 20, 2026: 53Aug 22, 2026: 52Aug 23, 2026: 52Aug 24, 2026: 51Aug 25, 2026: 52Aug 26, 2026: 51Aug 27, 2026: 51Aug 28, 2026: 49Aug 29, 2026: 49Aug 30, 2026: 49Aug 31, 2026: 49Sep 1, 2026: 51Sep 2, 2026: 51Sep 3, 2026: 53Sep 4, 2026: 50Sep 5, 2026: 50Sep 6, 2026: 50Sep 7, 2026: 50Sep 8, 2026: 49Sep 9, 2026: 47Sep 10, 2026: 45Sep 11, 2026: 43Sep 12, 2026: 44Sep 13, 2026: 44Sep 14, 2026: 42Sep 15, 2026: 44Sep 16, 2026: 44Sep 17, 2026: 45Sep 18, 2026: 45Sep 19, 2026: 45Sep 20, 2026: 45Sep 21, 2026: 46Sep 22, 2026: 48Sep 23, 2026: 48Sep 24, 2026: 46Sep 25, 2026: 44Sep 26, 2026: 43Sep 27, 2026: 43Sep 28, 2026: 45Sep 29, 2026: 46Sep 30, 2026: 47Oct 1, 2026: 46Oct 2, 2026: 44Oct 3, 2026: 44Oct 4, 2026: 44Oct 5, 2026: 44Oct 6, 2026: 44Oct 7, 2026: 45Oct 8, 2026: 44Oct 9, 2026: 45Oct 10, 2026: 45Oct 11, 2026: 45Oct 12, 2026: 45Oct 13, 2026: 42Oct 14, 2026: 42Oct 15, 2026: 42Oct 16, 2026: 40Oct 17, 2026: 40Oct 18, 2026: 41Oct 19, 2026: 41Oct 20, 2026: 42Oct 21, 2026: 39Oct 22, 2026: 36
Show the daily numbers
DateComposite
Oct 22, 202636
Oct 21, 202639
Oct 20, 202642
Oct 19, 202641
Oct 18, 202641
Oct 17, 202640
Oct 16, 202640
Oct 15, 202642
Oct 14, 202642
Oct 13, 202642
Oct 12, 202645
Oct 11, 202645
Oct 10, 202645
Oct 9, 202645
Oct 8, 202644
Oct 7, 202645
Oct 6, 202644
Oct 5, 202644
Oct 4, 202644
Oct 3, 202644
Oct 2, 202644
Oct 1, 202646
Sep 30, 202647
Sep 29, 202646
Sep 28, 202645
Sep 27, 202643
Sep 26, 202643
Sep 25, 202644
Sep 24, 202646
Sep 23, 202648
Sep 22, 202648
Sep 21, 202646
Sep 20, 202645
Sep 19, 202645
Sep 18, 202645
Sep 17, 202645
Sep 16, 202644
Sep 15, 202644
Sep 14, 202642
Sep 13, 202644
Sep 12, 202644
Sep 11, 202643
Sep 10, 202645
Sep 9, 202647
Sep 8, 202649
Sep 7, 202650
Sep 6, 202650
Sep 5, 202650
Sep 4, 202650
Sep 3, 202653
Sep 2, 202651
Sep 1, 202651
Aug 31, 202649
Aug 30, 202649
Aug 29, 202649
Aug 28, 202649
Aug 27, 202651
Aug 26, 202651
Aug 25, 202652
Aug 24, 202651
Aug 23, 202652
Aug 22, 202652
Aug 20, 202653
Aug 19, 202655
Aug 18, 202654
Aug 17, 202655
Aug 16, 202654
Aug 15, 202654
Aug 14, 202654
Aug 13, 202653
Aug 12, 202653
Aug 11, 202654
Aug 10, 202655
Aug 9, 202654
Aug 8, 202654
Aug 7, 202653
Aug 6, 202653
Aug 5, 202652
Aug 3, 202652
Aug 2, 202652
Jul 31, 202656
Jul 30, 202668
Jul 29, 202666
Jul 28, 202666
Jul 27, 202667
Jul 26, 202668
Jul 25, 202668

Key facts

Market cap
$2.4B
Sector
Healthcare
Industry
Biotechnology
Beta
0.94
Risk grade (1–10)
9
Next earnings
Oct 27, 2026

Biotechnology peers

CompanyMarket capScore
BEAM Beam Therapeutics$2.5B39
NAMS NewAmsterdam Pharma Company$2.5B39
ZLAB Zai Lab$2.5B37
ADMA ADMA Biologics$2.5B62
MBX MBX Biosciences$2.4B46
AUPH Aurinia Pharmaceuticals$2.3B76

Questions

What is RCUS's stock score today?

RCUS scores 36/100 (Bearish) as of Oct 22, 2026: technical 37, fundamental 35, and news sentiment 56, which is shown but not counted. Scores are recomputed every night.

Is RCUS a buy?

The score is not a buy or sell recommendation. A 36 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the RCUS score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.